QIAGEN N.V. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.64 USD | +0.74% |
|
+2.46% | -4.99% |
| 04-30 | QIAGEN NV : Berenberg reaffirms its Buy rating | ZD |
| 04-30 | QIAGEN : A decent start to 2024; guidance unchanged |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QIAGEN N.V. | Other Biotechnology & Medical Research | +0.52% | +2.46% | -4.99% | -7.81% | +6.82% | 9.39B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- QGEN Stock
- Charts Qiagen N.V.
- Comparison Chart
